ED Visits, Readmissions Common After CAR T Therapy ED Visits, Readmissions Common After CAR T Therapy

Toxicities associated with CAR T-cell therapy typically emerge in the first month after treatment, a new analysis suggests.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news